Ruthenium(II) Complexes Containing Anti-Inflammatory Drugs as Ligands: Synthesis, Characterization and in vitro Cytotoxicity Activities on Cancer Cell Lines

被引:22
|
作者
Lopes, Junai C. S. [1 ,2 ]
Damasceno, Jaqueline L. [3 ]
Oliveira, Pollyanna F. [3 ]
Guedes, AdrianaP. M. [4 ]
Tavares, Denise C. [3 ]
Deflon, Victor M. [5 ]
Lopes, Norberto P. [6 ]
Pivatto, Marcos [2 ]
Batista, Alzir A. [4 ]
Maia, Pedro I. S. [7 ]
Von Poelhsitz, Gustavo [2 ]
机构
[1] Inst Fed Norte Minas Gerais, BR-39270000 Pirapora, MG, Brazil
[2] Univ Fed Uberlandia, Dept Quim, BR-38400902 Uberlandia, MG, Brazil
[3] Univ Franca, BR-14404600 Franca, SP, Brazil
[4] Univ Fed Sao Carlos, Dept Quim, BR-13561901 Sao Carlos, SP, Brazil
[5] Univ Fed Sao Carlos, Inst Quim Sao Carlos, BR-13566590 Sao Carlos, SP, Brazil
[6] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, NPPNS, BR-14040903 Ribeirao Preto, SP, Brazil
[7] Univ Fed Triangulo Mineiro, Inst Ciencias Nat Exatas & Educ, BR-38064200 Uberaba, MG, Brazil
基金
巴西圣保罗研究基金会;
关键词
ruthenium(II) complexes; cytotoxic activity; sodium diclofenac; sodium ibuprofen; dppm; ANTICANCER AGENT; DNA; ELECTROCHEMISTRY; MONONUCLEAR; DICLOFENAC; CISPLATIN; THERAPY; BINDING; KP1019;
D O I
10.5935/0103-5053.20150161
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The synthesis, characterization and cytotoxic activity of cis-[Ru(dicl)(dppm)(2)]PF6 and cis-[Ru(ibu)(dppm)(2)]PF6, (dppm = 1,1-bis(diphenylphosphine)methane; dicl = diclofenac anion and ibu = ibuprofen anion), are described in this work. Complexes were characterized by elemental analysis, Fourier transform infrared spectroscopy (FTIR), UV-Vis, P-31{H-1} nuclear magnetic resonance (NMR) and high-resolution mass spectrometry (HRESIMS). X-ray structure of cis-[Ru(ibu)(dppm)(2)]PF6 is also described. Preliminary calf thymus DNA (ct-DNA) binding studies were carried out by UV-Vis and viscosity experiments, with results suggesting the existence of electrostatic interactions between ruthenium complexes and ct-DNA. Cytotoxicity assays were carried out on a panel of human cancer cell lines and a human normal cell line. Complexes displayed a high to moderate cytotoxicity with IC50 ranging from 5 to 47 mu mol L-1. cis-[Ru(ibu) (dppm)(2)]PF6 was found to be the most active, with IC50 values lower than cisplatin. The degree of cytotoxicity was maintained for the normal cell line, although cis-[Ru(ibu)(dppm)(2)]PF6 exhibited a similar selectivity to that of cisplatin but with a higher activity for at least two tumor cell lines which evidences a promising anticancer candidate and selects this complex for further experiments.
引用
收藏
页码:1838 / 1847
页数:10
相关论文
共 50 条
  • [1] Experimental and theoretical investigations of cyclometalated ruthenium(ii) complex containing CCC-pincer and anti-inflammatory drugs as ligands: synthesis, characterization, inhibition of cyclooxygenase and in vitro cytotoxicity activities in various cancer cell lines
    Tabrizi, Leila
    Olasunkanmi, Lukman O.
    Fadare, Olatomide A.
    [J]. DALTON TRANSACTIONS, 2019, 48 (02) : 728 - 740
  • [2] Ruthenium(II) polypyridyl complexes with hydroxypyridine mixed ligands: Synthesis, characterization and in vitro cell cytotoxicity
    Obaleye, Joshua
    Rajee, Abdullahi
    Ajibola, Abiodun
    Babamale, Halimat
    Bamigboye, Mercy
    Obaleye, Peter
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [3] Synthesis and in vitro cytotoxicity of some ruthenium(II) complexes against human cancer cell lines
    Mazumder, UK
    Gupta, M
    Bhattacharya, S
    Karki, SS
    Manikandan, L
    Roy, M
    Chakraborty, S
    Suresh, R
    [J]. DRUG METABOLISM REVIEWS, 2003, 35 : 213 - 213
  • [4] Synthesis, characterization and cytotoxicity of cyclopentadienyl ruthenium(II) complexes containing carbohydrate-derived ligands
    Florindo, Pedro
    Marques, Ines J.
    Nunes, Carla D.
    Fernandes, Ana C.
    [J]. JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2014, 760 : 240 - 247
  • [5] Synthesis, characterization, DNA interaction and in vitro cytotoxicity activities of ruthenium(II) Schiff base complexes
    Sathiyaraj, Subbaiyan
    Butcher, Ray J.
    Jayabalakrishnan, Chinnasamy
    [J]. JOURNAL OF MOLECULAR STRUCTURE, 2012, 1030 : 95 - 103
  • [6] Synthesis, characterization, DNA binding, DNA cleavage, antioxidant and in vitro cytotoxicity studies of ruthenium(II) complexes containing hydrazone ligands
    Mohanraj, Maruthachalam
    Ayyannan, Ganesan
    Raja, Gunasekaran
    Jayabalakrishnan, Chinnasamy
    [J]. JOURNAL OF COORDINATION CHEMISTRY, 2016, 69 (23) : 3545 - 3559
  • [7] Ruthenium(II)/4,6-dimethyl-2-mercaptopyrimidine complexes: Synthesis, characterization, X-ray structures and in vitro cytotoxicity activities on cancer cell lines
    Mondelli, Melina A.
    Graminha, Angelica E.
    Correa, Rodrigo S.
    da Silva, Monize M.
    Carnizello, Andrea P.
    Von Poelhsitz, Gustavo
    Ellena, Javier
    Deflon, Victor M.
    Caramori, Giovanni F.
    Torre, Maria H.
    Tavares, Denise C.
    Batista, Alzir A.
    [J]. POLYHEDRON, 2014, 68 : 312 - 318
  • [8] Ruthenium(II)-arene complexes containing ferrocenamide ligands: Synthesis, characterisation and antiproliferative activity against cancer cell lines
    Mandal, Poulami
    Sonkar, Chanchal
    Dhankhar, Sandeep Singh
    Nagaraja, C. M.
    Mukhopadhyay, Suman
    [J]. JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2020, 916
  • [9] Synthesis, characterization, photocleavage, cytotoxicity in vitro, apoptosis, and cell cycle arrest of ruthenium(II) complexes
    Guo, Qi-Feng
    Liu, Si-Hong
    Liu, Qing-Hua
    Xu, Hui-Hua
    Zhao, Jian-Hua
    Wu, Hai-Feng
    Li, Xin-Yan
    Wang, Jian-Wei
    [J]. JOURNAL OF COORDINATION CHEMISTRY, 2012, 65 (10) : 1781 - 1791
  • [10] Synthesis, characterization, and evaluation of biological activities of new 4′-substituted ruthenium (II) terpyridine complexes: Prospective anti-inflammatory properties
    Elnagar, Mohamed M.
    Samir, Safia
    Shaker, Yasser M.
    Abdel-Shafi, Ayman A.
    Sharmoukh, Walid
    Abdel-Aziz, Mohamed S.
    Abou-El-Sherbini, Khaled S.
    [J]. APPLIED ORGANOMETALLIC CHEMISTRY, 2021, 35 (01)